Hidradenitis Suppurativa (part 1): definition, epidemiology, etiology, diagnosis.

Q4 Medicine
O. Olisova, E. V. Sokolovskiy, V. Khairutdinov, Muza Kokhan, M. Rakhmatulina, S. Burova, L. Kotrekhova, A. Pirogova
{"title":"Hidradenitis Suppurativa (part 1): definition, epidemiology, etiology, diagnosis.","authors":"O. Olisova, E. V. Sokolovskiy, V. Khairutdinov, Muza Kokhan, M. Rakhmatulina, S. Burova, L. Kotrekhova, A. Pirogova","doi":"10.25208/vdv14876","DOIUrl":null,"url":null,"abstract":"Hidradenitis Suppurativa (HS) is a chronic recurrent skin disease characterized by development of autoimmune inflammation in the infundibulum of the hair follicle and apocrine sweat glands located in the axillary, inguinal, anogenital regions, submammary folds, near the areola of mammary glands and the umbilical region. HS is difficult to treat and has an extremely negative impact on the quality of life. HS is separated into a distinct clinical entity fundamentally different in etiopathogenesis from acute bacterial hidradenitis. The exact prevalence of HS is unknown, it varies greatly in different studies ranging from 0.03% to 4% in general population. The detection of IL-1, IL-23, and IL-17 in the lesions indicates the key role of autoimmune inflammation involving Th17-lymphocytes in the pathogenesis of HS. Risk factors include smoking, obesity, mechanical friction, genetic predisposition. The diagnosis of HS relies on three obligatory criteria: characteristic distribution, typical morphology of the lesions and relapsing, chronic disease course. There is no gold standard in assessing the severity of the disease, since all available scoring systems have many limitations, therefore many questions regarding this disease remain unsolved at present - from terminology and clear and most objective assessment criteria for the severity of the process to the development of native clinical guidelines.","PeriodicalId":23618,"journal":{"name":"Vestnik dermatologii i venerologii","volume":"54 19","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vestnik dermatologii i venerologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25208/vdv14876","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Hidradenitis Suppurativa (HS) is a chronic recurrent skin disease characterized by development of autoimmune inflammation in the infundibulum of the hair follicle and apocrine sweat glands located in the axillary, inguinal, anogenital regions, submammary folds, near the areola of mammary glands and the umbilical region. HS is difficult to treat and has an extremely negative impact on the quality of life. HS is separated into a distinct clinical entity fundamentally different in etiopathogenesis from acute bacterial hidradenitis. The exact prevalence of HS is unknown, it varies greatly in different studies ranging from 0.03% to 4% in general population. The detection of IL-1, IL-23, and IL-17 in the lesions indicates the key role of autoimmune inflammation involving Th17-lymphocytes in the pathogenesis of HS. Risk factors include smoking, obesity, mechanical friction, genetic predisposition. The diagnosis of HS relies on three obligatory criteria: characteristic distribution, typical morphology of the lesions and relapsing, chronic disease course. There is no gold standard in assessing the severity of the disease, since all available scoring systems have many limitations, therefore many questions regarding this disease remain unsolved at present - from terminology and clear and most objective assessment criteria for the severity of the process to the development of native clinical guidelines.
湿疹(第 1 部分):定义、流行病学、病因学、诊断。
化脓性扁桃体炎(HS)是一种慢性复发性皮肤病,其特征是位于腋窝、腹股沟、肛门周围、乳房下皱襞、乳腺乳晕附近和脐部的毛囊和大汗腺基底发生自身免疫性炎症。HS 难以治疗,对生活质量有极大的负面影响。HS 是一种不同的临床实体,其发病机制与急性细菌性扁桃体炎根本不同。HS 的确切发病率尚不清楚,在不同的研究中差异很大,在普通人群中的发病率从 0.03% 到 4% 不等。皮损中检测到的IL-1、IL-23和IL-17表明,Th17淋巴细胞参与的自身免疫炎症在HS的发病机制中起着关键作用。危险因素包括吸烟、肥胖、机械摩擦、遗传易感性。HS 的诊断依赖于三个强制性标准:特征性分布、典型的皮损形态和复发性慢性病程。由于所有可用的评分系统都有许多局限性,因此目前还没有评估疾病严重程度的金标准,因此有关该疾病的许多问题仍悬而未决--从术语、明确和最客观的疾病严重程度评估标准到本地临床指南的制定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
40
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信